Evidence map›Paper›PMID 35179409›Full record

ArticleTechnology in cancer research & treatment

Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.

Ziwei Liang, Enyu Zhang, Ling Duan, Nathaniel Weygant, Guangyu An, Bin Hu, Jiannan Yao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ziwei LiangBeijing Chao-Yang Hospital, 74639Capital Medical University, Beijing, China.
Enyu Zhang71043Beijing Fu Xing Hospital, Capital Medical University, Beijing, China.
Ling DuanBeijing Chao-Yang Hospital, 74639Capital Medical University, Beijing, China.
Nathaniel Weygant47858Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Guangyu AnBeijing Chao-Yang Hospital, 74639Capital Medical University, Beijing, China.
Bin HuDepartment of Thoracic Surgery, Beijing Chao-Yang Hospital, 74639Capital Medical University, Beijing, China.ORCID 0000-0001-9598-883X
Jiannan YaoBeijing Chao-Yang Hospital, 74639Capital Medical University, Beijing, China.ORCID 0000-0002-4982-4460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansLungNomogramsRetrospective StudiesSEER Programcompeting risk modelnomogramprognostic factorpulmonary sarcomatoid carcinomaSEER

Identifiers

PMID35179409
PMCPMC8859694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.